Tenet Reports Results for the First Quarter Ended March 31, 2018

Go back to Tenet Reports Results for the First Quarter Ended March 31, 2018

Tenet Healthcare (THC) PT Raised to $30 at RBC Capital

May 2, 2018 8:45 AM EDT

RBC Capital raised its price target on Tenet Healthcare (NYSE: THC) to $30.00 (from $21.00) while maintaining a Sector Perform rating.

Analyst Frank Morgan commented, "THC exceeded expectations and the high end of guidance for 1Q18, largely driven by outperformance at Conifer through accelerated cost... More